Hepatic Encephalopathy
HE High-yield Verified · Sep 2026Hepatic encephalopathy is a spectrum of neuropsychiatric abnormalities caused by neurotoxic substances that accumulate in the blood of patients with liver dysfunction or portosystemic shunting; it is a diagnosis of exclusion.
Early hepatic encephalopathy looks like day–night reversal and a shorter attention span; later come asterixis, disorientation, somnolence and coma. Most episodes have a precipitant, and removing it can be enough. Lactulose is titrated to 2 or 3 soft stools daily, rifaximin is added to prevent recurrence, protein is not restricted, and sedatives are avoided.
What’s going wrong in the body
The normal physiology, where it fails, and why the body’s compensation backfires.
01 Gut ammonia that the liver no longer clears
"Colonic bacteria and mucosal enzymes break down dietary proteins, releasing ammonia in the gastrointestinal tract. This ammonia is normally absorbed into the portal circulation, where the liver converts it into urea through the urea cycle. However, in cases of hepatic failure or systemic shunting, ammonia can accumulate and bypass the liver, entering the systemic circulation." Normally, "ammonia is converted to urea in the liver and then subsequently cleared by kidneys. A small amount is also cleared by skeletal muscle via glutamate" (Patidar & Bajaj).
Two routes around the liver. "Symptoms may result from liver insufficiency or the diversion of blood flow away from the liver (portosystemic shunting)." A transjugular intrahepatic portosystemic shunt (TIPS) is one such route: "hepatic encephalopathy can complicate 30% to 50% of cirrhosis patients who undergo TIPS" (StatPearls).
Muscle matters. "A small amount is also cleared by skeletal muscle via glutamate" (Patidar & Bajaj), and sarcopenia — "decreased muscle mass, strength, and function" — "is associated with an increased risk of hepatic encephalopathy" (StatPearls).
02 What ammonia does in the brain — and why it is not the whole story
"Elevated ammonia levels cause astrocyte swelling, oxidative stress, and neurotransmitter imbalances, all of which contribute to hepatic encephalopathy. Other contributing factors include systemic inflammation and changes to the blood-brain barrier. Additionally, alterations in the gut microbiome have a significant role in ammonia production and the development of hepatic encephalopathy."
More than ammonia. Understanding has moved from hyperammonemia alone to "a complex interplay of factors, including systemic inflammation, gut dysbiosis, altered neurotransmitters, and other neurotoxins such as manganese." Patidar & Bajaj list "ammonia, inflammatory cytokines, benzodiazepine-like compounds, and manganese deposition." This is why "ammonia levels do not always correlate with symptom severity."
[ALF] Acute liver failure is different. In the brain, "astrocytic glutamine synthetase converts it along with glutamate into glutamine. Glutamine acts as an osmolyte, leading to an increase in cerebral volume. This causes brain edema and intracranial hypertension, as well as increases the risk of brain herniation." Cerebral edema is "relatively rare" at West Haven grade 1 or 2 but is seen in about 25% to 35% at grade 3 and about 75% at grade 4 (StatPearls).
03 Triggers tip a compensated patient into overt HE
Most episodes are provoked. KASL: "The precipitating factor can be identified in 80–90% of patients with HE" and "In many cases, HE can be improved simply by eliminating the precipitating factor." StatPearls lists gastrointestinal bleeding (eg, acute variceal bleeding), constipation, infections, dehydration (from fluid restriction, diuretics, diarrhea, vomiting or excessive paracentesis), electrolyte imbalances such as hyponatremia and hypokalemia, alcohol use disorder, medications (benzodiazepines, opioids, NSAIDs), and kidney dysfunction and azotemia. Infections include "spontaneous bacterial peritonitis or urinary tract infections."
The trigger list is the nursing checklist. GI bleeding, constipation, infection, dehydration, diuretics and low potassium are all named triggers, and sedatives "can potentially exacerbate encephalopathy and impede recovery." A shunt or TIPS lets portal blood bypass the liver.
How treatment reverses it. Lactulose acidifies the colon: "This acidification of colonic contents results in the retention of ammonia in the colon as the ammonium ion," and it "also exerts an osmotic effect in the colon, promoting distention and peristalsis, which facilitates the excretion of NH3." Rifaximin is "believed to reduce ammonia production by targeting and eliminating ammonia-producing bacteria in the colon."
Causes & risk factors
Modifiable factors are teaching targets — the patient can act on them.
Signs & symptoms
Each finding tied to the mechanism that produces it — and the triage it calls for.
Diagnostics
Complications
Medications for this condition
Why each class is prescribed here — every card links to its full pharmacology page.
Lactulose — first-line. Label indication: "For the prevention and treatment of portal-systemic encephalopathy, including the stages of hepatic pre-coma and coma." The dose is adjusted "to produce 2 or 3 soft stools daily" (label); StatPearls: "About 70% to 80% of patients with hepatic encephalopathy show improvement with lactulose treatment." In acute overt HE it is repeated until the first bowel movement, then titrated. When the patient is in the coma stage "and the danger of aspiration exists," it is given as a retention enema, and "Cleansing enemas containing soap suds or other alkaline agents should not be used." It is also used for secondary prevention after an episode. Too much causes diarrhea, fluid loss, hypokalemia and hypernatremia. Contains galactose and lactose, so use "with caution in diabetes."
Avoid — a precipitant. Benzodiazepines are on the StatPearls trigger list and "can potentially exacerbate encephalopathy and impede recovery"; the KASL work-up table says to stop the benzodiazepine. Lorazepam can itself cause asterixis. Flumazenil "is not a recommended treatment for hepatic encephalopathy."
Avoid or question — a precipitant. Opioids are on the StatPearls trigger list with benzodiazepines, and the KASL table directs stopping the opioid (naloxone listed). Drugs "may remain in the body for extended periods due to the liver's impaired ability to metabolize them" (StatPearls).
Beyond medications
- Find and correct the precipitant first — bleeding, infection, constipation, dehydration, electrolyte problems, sedatives. KASL (A1): "those factors should be recognized and managed."
- Rifaximin (no class page) — Xifaxan is "indicated for reduction in risk of overt hepatic encephalopathy (HE) recurrence in adults," 550 mg twice daily. In its trial "91% of the patients were using lactulose concomitantly," and it "significantly reduced the risk of HE-related hospitalizations by 50%." It stays in the gut: it is "non-absorbable." Label cautions: C. difficile-associated diarrhea (from mild diarrhea to "fatal colitis"), use with caution in severe (Child-Pugh C) hepatic impairment, "Monitor INR and prothrombin time" with warfarin, and hypersensitivity including anaphylaxis.
- Nutrition — do not restrict protein. "Patients with hepatic encephalopathy should not have their protein intake restricted." StatPearls targets about 35 to 40 kcal/kg/day and 1.2 to 1.5 g/kg/day of protein; KASL: "Long-term protein restriction should be avoided because it can induce protein catabolism, hepatic dysfunction, and sarcopenia." Vegetable protein is an option if protein worsens symptoms.
- Avoid fasting — "People with cirrhosis should avoid fasting, or going without food, for too long" (NIDDK): smaller, more frequent meals, eating every 3 or 4 hours while awake, and "having a snack before going to sleep at night or having an early breakfast after waking up."
- Hydration and electrolytes — oral fluids, IV hydration when needed, and correction of electrolyte abnormalities.
- Stop alcohol and hepatotoxins — "You should completely stop drinking alcohol because it can cause more liver damage" (NIDDK); avoid "certain herbal medications, or unapproved dietary supplements."
- Not recommended: neomycin and metronidazole (KASL — side effects such as malabsorption and nephrotoxicity); routine BCAA infusions; flumazenil.
- Refractory or shunt-related HE — shunt closure (BRTO or PARTO) "can be effective for patients with refractory hepatic encephalopathy caused by portosystemic shunts"; liver transplantation is the only cure.
Nursing considerations
The RN-specific layer — each action paired with the reason it matters.
How a real nurse thinks
The clinical-judgment loop, worked for a typical presentation — reasoning, not reference.
- 1 Recognize cues
Disorientation, day–night reversal, asterixis, agitation. Triggers present: no stool for 3 days, new diuretics with low potassium and sodium. A sedative is about to be ordered.
- 2 Analyze cues
This is overt HE (at least West Haven grade 2): "the appearance of disorientation or asterixis." Constipation, diuretics and hypokalemia are named precipitants, and benzodiazepines "can potentially exacerbate encephalopathy and impede recovery." Normal glucose makes hypoglycemia unlikely as the cause.
- 3 Prioritize
Safety and the triggers come first: prevent injury and aspiration, avoid the sedative, and get the stool count up. The ammonia value itself is not the target.
- 4 Generate solutions
Question the lorazepam order; ask about the lactulose dose, potassium replacement and the diuretics; set up fall and aspiration precautions.
- 5 Take action
SBAR: 58-year-old with cirrhosis, now disoriented with asterixis at 0300; no BM for 3 days, K 3.1, Na 131 on new diuretics. Concern for worsening hepatic encephalopathy with constipation and hypokalemia as triggers. Request: hold the lorazepam, review lactulose dosing to reach 2–3 soft stools, potassium replacement and diuretic orders. Give lactulose as ordered and keep him safe from falls and aspiration.
- 6 Evaluate
Reassess orientation, asterixis and stool count through the day; escalate at once if he becomes hard to wake, vomits blood or passes black stools, or develops fever with abdominal pain.
Scenario — you’re the nurse
Work each question before revealing the answer. Rationales explain the wrong options too.
A 58-year-old man with alcohol-related cirrhosis and ascites was admitted yesterday with one day of confusion. He takes lactulose at home and started furosemide and spironolactone last week. His last bowel movement was 3 days ago.
Q1 Multiple choice Which finding best indicates that this patient has progressed to overt hepatic encephalopathy? - A. Elevated serum ammonia level
- B. Disorientation with a flapping tremor of the outstretched hands
- C. Palmar erythema
- D. Two soft stools yesterday
Reveal answer & rationale
Q2 Select all that apply Which factors can precipitate hepatic encephalopathy? Select all that apply. - A. Constipation
- B. Gastrointestinal bleeding
- C. Hypokalemia from diuretics
- D. Benzodiazepines
- E. Spontaneous bacterial peritonitis
- F. A bedtime snack
Reveal answer & rationale
Q3 Multiple choice The covering provider asks for lorazepam for the patient's agitation. What is the nurse's best response? - A. Give it and recheck orientation in 4 hours
- B. Question the order, because sedatives such as benzodiazepines can worsen encephalopathy, and use safety measures instead
- C. Give half the dose because of the liver disease
- D. Apply restraints first and then give the lorazepam
Reveal answer & rationale
Q4 Multiple choice The patient becomes difficult to rouse and cannot swallow safely. Lactulose is ordered. How should the nurse expect it to be given? - A. Hold all lactulose until he is awake
- B. As a retention enema via rectal balloon catheter
- C. As a soap-suds cleansing enema
- D. Orally with thickened fluids
Reveal answer & rationale
Q5 Multiple choice Which statement by the caregiver shows correct understanding of home management? - A. He should eat very little protein from now on
- B. If he has 5 or 6 watery stools a day, the lactulose is working better
- C. He should take lactulose so he has 2 to 3 soft bowel movements a day, and he should not drive
- D. A sleeping pill will help fix his night-time wakefulness
Reveal answer & rationale
Common questions
What causes hepatic encephalopathy?
Should the nurse trend ammonia levels to judge treatment?
Why is protein no longer restricted?
How many stools should lactulose produce?
What does rifaximin add?
Is every flapping tremor hepatic encephalopathy?
Sources
- Hepatic Encephalopathy — StatPearls — StatPearls (NCBI Bookshelf)
- Lactulose — StatPearls — StatPearls (NCBI Bookshelf)
- Rifaximin — StatPearls — StatPearls (NCBI Bookshelf)
- Asterixis — StatPearls — StatPearls (NCBI Bookshelf)
- XIFAXAN (rifaximin) tablets — FDA label (DailyMed) — U.S. Food and Drug Administration / DailyMed
- Lactulose Solution USP — FDA label (DailyMed) — U.S. Food and Drug Administration / DailyMed
- Treatment for Cirrhosis — National Institute of Diabetes and Digestive and Kidney Diseases (NIH)
- Eating, Diet, & Nutrition for Cirrhosis — National Institute of Diabetes and Digestive and Kidney Diseases (NIH)
- Covert and Overt Hepatic Encephalopathy: Diagnosis and Management (Patidar & Bajaj, 2015; NIH author manuscript) — Clinical Gastroenterology and Hepatology (PMC)
- KASL clinical practice guidelines for liver cirrhosis: Varices, hepatic encephalopathy, and related complications (2020) — Korean Association for the Study of the Liver / Clinical and Molecular Hepatology (PMC)
Reviewed by Hae Suk Lee, RN
Educational summary for nursing students. Scenarios are fictional teaching cases. Always verify against current guidelines and your institution's protocols before acting in practice. Not medical advice.